{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:05:59Z","timestamp":1790654759512,"version":"4.1.0"},"reference-count":32,"publisher":"Manuscript Technomedia LLP","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phcog Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/pr.pr_8_17","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T10:25:54Z","timestamp":1499855154000},"page":"247","source":"Crossref","is-referenced-by-count":19,"title":["Ameliorative effect of curcumin on olanzapine-induced obesity in Sprague-Dawley rats"],"prefix":"10.5530","volume":"9","author":[{"given":"Subramani","family":"Parasuraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KhorMing","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmila","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ParayilVarghese","family":"Christapher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3478","reference":[{"key":"key-10.4103\/0974-8490.210325-1","first-page":"1719","volume-title":"Association of olanzapine-induced weight gain with an increase in body fat","author":"Eder","year":"2001","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0974-8490.210325-2","first-page":"842","volume-title":"Body weight changes associated with psychopharmacology","author":"Vanina","year":"2002","journal-title":"Psychiatr Serv"},{"key":"key-10.4103\/0974-8490.210325-3","first-page":"2086","volume-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"key":"key-10.4103\/0974-8490.210325-4","doi-asserted-by":"crossref","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96.","DOI":"10.1176\/ajp.156.11.1686"},{"key":"key-10.4103\/0974-8490.210325-5","first-page":"527","volume-title":"Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients","author":"Bustillo","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"key-10.4103\/0974-8490.210325-6","first-page":"477","volume-title":"Pharmacological management of atypical antipsychotic-induced weight gain","author":"Baptista","year":"2008","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0974-8490.210325-7","first-page":"173","volume-title":"Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals","author":"Aggarwal","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"key-10.4103\/0974-8490.210325-8","first-page":"1670","volume-title":"Hypolipidemic effect of myricetin","author":"Liang","year":"2009","journal-title":"Chin J Lab Diagn"},{"key":"key-10.4103\/0974-8490.210325-9","first-page":"40","volume-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","author":"Aggarwal","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key-10.4103\/0974-8490.210325-10","first-page":"1233","volume-title":"Potentials of curcumin as an antidepressant","author":"Kulkarni","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"key-10.4103\/0974-8490.210325-11","first-page":"43","volume-title":"Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats","author":"Kumar","year":"2010","journal-title":"J Biomed Sci"},{"key":"key-10.4103\/0974-8490.210325-12","first-page":"25","volume-title":"Effects of curcumin and telmisartan on olanzapine and high fructose diet-induced metabolic syndrome in Spraugue-Dawley rats","author":"Ramesh","year":"2012","journal-title":"Pharmacogn J"},{"key":"key-10.4103\/0974-8490.210325-13","first-page":"80","volume-title":"A parametric analysis of olanzapine-induced weight gain in female rats","author":"Cooper","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"key-10.4103\/0974-8490.210325-14","first-page":"89","volume-title":"Evaluation of sub-chronic toxic effects of petroleum ether, a laboratory solvent in Sprague-Dawley rats","author":"Parasuraman","year":"2014","journal-title":"J Basic Clin Pharm"},{"key":"key-10.4103\/0974-8490.210325-15","first-page":"88","volume-title":"log (TG)\/HDL-C is related to both residual cardiometabolic risk and \u00df-cell function loss in type 2 diabetes males","author":"Hermans","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"key-10.4103\/0974-8490.210325-16","first-page":"88","volume-title":"Antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Linn.) in streptozotocin-induced diabetic rats","author":"Petchi","year":"2013","journal-title":"J Basic Clin Pharm"},{"key":"key-10.4103\/0974-8490.210325-17","first-page":"36","volume-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","author":"Albaugh","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"key-10.4103\/0974-8490.210325-18","first-page":"e104160","volume-title":"Preventing olanzapine-induced weight gain using betahistine: A study in a rat model with chronic olanzapine treatment","author":"Lian","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0974-8490.210325-19","first-page":"639391","volume-title":"The effect of ranitidine on olanzapine-induced weight gain","author":"Ranjbar","year":"2013","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0974-8490.210325-20","first-page":"284","volume-title":"Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats","author":"Raskind","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"key-10.4103\/0974-8490.210325-21","first-page":"130","volume-title":"Olanzapine affects locomotor activity and meal size in male rats","author":"van","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"key-10.4103\/0974-8490.210325-22","first-page":"244","volume-title":"Antipsychotics and abnormal liver function tests: Systematic review","author":"Marwick","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"key-10.4103\/0974-8490.210325-23","first-page":"394","volume-title":"Possible olanzapine-induced hepatotoxicity in a young Chinese patient","author":"Lui","year":"2009","journal-title":"Hong Kong Med J"},{"key":"key-10.4103\/0974-8490.210325-24","first-page":"1163","volume-title":"Severe liver enzyme elevations after three years of olanzapine treatment: A case report and review of olanzapine associated hepatotoxicity","author":"Ozcanli","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key-10.4103\/0974-8490.210325-25","first-page":"698","volume-title":"Olanzapine induced biochemical and histopathological changes after its chronic administration in rats","author":"Shah","year":"2016","journal-title":"Saudi Pharm J"},{"key":"key-10.4103\/0974-8490.210325-26","first-page":"1576","volume-title":"Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters","author":"Jang","year":"2008","journal-title":"Metabolism"},{"key":"key-10.4103\/0974-8490.210325-27","first-page":"994","volume-title":"Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin","author":"Abouzeid","year":"2013","journal-title":"J Drug Target"},{"key":"key-10.4103\/0974-8490.210325-28","first-page":"149","volume-title":"An overview of curcumin in neurological disorders","author":"Kulkarni","year":"2010","journal-title":"Indian J Pharm Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0250-474X","issn-type":"print"},{"key":"key-10.4103\/0974-8490.210325-29","first-page":"3010","volume-title":"Bisphenol-A mediated inhibition of hippocampal neurogenesis attenuated by curcumin via canonical Wnt pathway","author":"Tiwari","year":"2016","journal-title":"Mol Neurobiol"},{"key":"key-10.4103\/0974-8490.210325-30","first-page":"197","volume-title":"Receptor mechanisms of antipsychotic drug action in bipolar disorder-focus on asenapine","author":"Reynolds","year":"2011","journal-title":"Ther Adv Psychopharmacol"},{"key":"key-10.4103\/0974-8490.210325-31","first-page":"35","volume-title":"Compensatory weight gain due to dopaminergic hypofunction: New evidence and own incidental observations","author":"Reinholz","year":"2008","journal-title":"Nutr Metab (Lond)"},{"key":"key-10.4103\/0974-8490.210325-32","unstructured":"Open-Label Study of Curcumin C-3 Complex in Schizophrenia. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT01875822?view=record. [Last accessed on 2016 Apr 23]."}],"container-title":["Pharmacognosy Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:39:00Z","timestamp":1769593140000},"score":1,"resource":{"primary":{"URL":"https:\/\/phcogres.com\/article\/9\/3\/247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["210325"],"URL":"https:\/\/doi.org\/10.4103\/pr.pr_8_17","relation":{},"ISSN":["0974-8490"],"issn-type":[{"value":"0974-8490","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}